annual retained earnings:
$3.16B+$1.66B(+110.39%)Summary
- As of today (April 13, 2025), AZN annual retained earnings is $3.16 billion, with the most recent change of +$1.66 billion (+110.39%) on December 31, 2024.
- During the last 3 years, AZN annual retained earnings has risen by +$1.45 billion (+84.80%).
- AZN annual retained earnings is now -82.71% below its all-time high of $18.27 billion, reached on December 31, 2010.
Performance
AZN Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
N/ASummary
- AZN quarterly retained earnings is not available.
Performance
AZN quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AZN Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +110.4% | - |
| 3 y3 years | +84.8% | - |
| 5 y5 years | +12.4% | - |
AZN Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +650.5% | ||
| 5 y | 5-year | -40.4% | +650.5% | ||
| alltime | all time | -82.7% | +650.5% |
AstraZeneca Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $3.16B(+110.4%) | - |
| Sep 2024 | - | $3.14B(+69.9%) |
| Jun 2024 | - | $1.85B(-971.2%) |
| Mar 2024 | - | -$212.00M(-51.2%) |
| Dec 2023 | $1.50B(-361.7%) | - |
| Sep 2023 | - | -$434.00M(+85.5%) |
| Jun 2023 | - | -$234.00M(-87.2%) |
| Mar 2023 | - | -$1.82B(+217.9%) |
| Dec 2022 | -$574.00M(-133.6%) | -$574.00M(-76.8%) |
| Sep 2022 | - | -$2.47B(+49.1%) |
| Jun 2022 | - | -$1.66B(+34.9%) |
| Mar 2022 | - | -$1.23B(-171.8%) |
| Dec 2021 | $1.71B(-67.7%) | $1.71B(-22.3%) |
| Sep 2021 | - | $2.20B(-58.8%) |
| Jun 2021 | - | $5.33B(+30.5%) |
| Mar 2021 | - | $4.09B(-22.8%) |
| Dec 2020 | $5.30B(+88.4%) | $5.30B(+182.5%) |
| Sep 2020 | - | $1.88B(-1.9%) |
| Jun 2020 | - | $1.91B(+327.0%) |
| Mar 2020 | - | $448.00M(-84.1%) |
| Dec 2019 | $2.81B(-50.5%) | $2.81B(+50.8%) |
| Sep 2019 | - | $1.86B(-42.9%) |
| Jun 2019 | - | $3.27B(-11.3%) |
| Mar 2019 | - | $3.68B(-35.2%) |
| Dec 2018 | $5.68B(-30.9%) | $5.68B(+10.1%) |
| Sep 2018 | - | $5.16B(-12.2%) |
| Jun 2018 | - | $5.88B(-4.6%) |
| Mar 2018 | - | $6.16B(-25.0%) |
| Dec 2017 | $8.22B(+1.0%) | $8.22B(+17.4%) |
| Sep 2017 | - | $7.00B(+1.0%) |
| Jun 2017 | - | $6.93B(+10.6%) |
| Mar 2017 | - | $6.26B(-23.1%) |
| Dec 2016 | $8.14B(-31.2%) | $8.14B(+27.6%) |
| Sep 2016 | - | $6.38B(-7.0%) |
| Jun 2016 | - | $6.86B(-15.1%) |
| Mar 2016 | - | $8.07B(-31.8%) |
| Dec 2015 | $11.83B(-9.2%) | $11.83B(+10.5%) |
| Sep 2015 | - | $10.71B(-8.1%) |
| Jun 2015 | - | $11.65B(+13.0%) |
| Mar 2015 | - | $10.30B(-20.9%) |
| Dec 2014 | $13.03B(-23.2%) | $13.03B(-6.2%) |
| Sep 2014 | - | $13.89B(-10.4%) |
| Jun 2014 | - | $15.50B(+3.4%) |
| Mar 2014 | - | $14.99B(-11.6%) |
| Dec 2013 | $16.96B(-5.5%) | $16.96B(-1.4%) |
| Sep 2013 | - | $17.20B(+0.1%) |
| Jun 2013 | - | $17.18B(+5.0%) |
| Mar 2013 | - | $16.37B(-8.8%) |
| Dec 2012 | $17.95B | $17.95B(+9.9%) |
| Sep 2012 | - | $16.33B(-0.5%) |
| Jun 2012 | - | $16.41B(+2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $16.03B(-10.4%) |
| Dec 2011 | $17.89B(-2.1%) | $17.89B(-3.9%) |
| Sep 2011 | - | $18.61B(+1.5%) |
| Jun 2011 | - | $18.34B(+5.8%) |
| Mar 2011 | - | $17.33B(-5.1%) |
| Dec 2010 | $18.27B(+12.8%) | $18.27B(+6.0%) |
| Sep 2010 | - | $17.23B(-1.1%) |
| Jun 2010 | - | $17.42B(+8.0%) |
| Mar 2010 | - | $16.14B(-0.4%) |
| Dec 2009 | $16.20B(+40.0%) | $16.20B(+8.1%) |
| Sep 2009 | - | $14.99B(+11.5%) |
| Jun 2009 | - | $13.44B(+21.9%) |
| Mar 2009 | - | $11.02B(-4.8%) |
| Dec 2008 | $11.57B(+8.9%) | $11.57B(-2.1%) |
| Sep 2008 | - | $11.82B(+0.2%) |
| Jun 2008 | - | $11.80B(+11.5%) |
| Mar 2008 | - | $10.59B(-0.4%) |
| Dec 2007 | $10.62B(-6.4%) | $10.62B(+1.1%) |
| Sep 2007 | - | $10.51B(-2.4%) |
| Jun 2007 | - | $10.76B(+8.3%) |
| Mar 2007 | - | $9.94B(-12.4%) |
| Dec 2006 | $11.35B(+6.3%) | $11.35B(+4.9%) |
| Sep 2006 | - | $10.82B(-3.7%) |
| Jun 2006 | - | $11.23B(-1.0%) |
| Mar 2006 | - | $11.35B(+6.3%) |
| Dec 2005 | $10.68B(-7.9%) | $10.68B(+3.0%) |
| Sep 2005 | - | $10.37B(-2.1%) |
| Jun 2005 | - | $10.60B(-0.8%) |
| Mar 2005 | - | $10.68B(-7.9%) |
| Dec 2004 | $11.59B(+10.9%) | $11.59B(+11.0%) |
| Sep 2004 | - | $10.44B(+5.6%) |
| Jun 2004 | - | $9.89B(+3.5%) |
| Mar 2004 | - | $9.56B(-8.5%) |
| Dec 2003 | $10.45B(+23.6%) | $10.45B(+23.6%) |
| Dec 2002 | $8.45B(+22.4%) | $8.45B(+22.4%) |
| Dec 2001 | $6.90B(-0.8%) | $6.90B(-0.8%) |
| Dec 2000 | $6.96B(-18.5%) | $6.96B(-18.5%) |
| Dec 1999 | $8.54B(+599.8%) | $8.54B(+235.7%) |
| Sep 1999 | - | $2.54B(+499.8%) |
| Jun 1999 | - | $424.00M(-65.2%) |
| Dec 1998 | $1.22B(-50.2%) | $1.22B(-57.8%) |
| Jun 1998 | - | $2.89B(+18.0%) |
| Dec 1997 | $2.45B(+18.4%) | $2.45B(+18.4%) |
| Dec 1996 | $2.07B(+25.5%) | $2.07B(+25.5%) |
| Dec 1995 | $1.65B(+10.3%) | $1.65B(-17.0%) |
| Jun 1995 | - | $1.99B(+32.9%) |
| Dec 1994 | $1.49B(+25.2%) | $1.49B(+25.2%) |
| Dec 1993 | $1.19B(-4.8%) | $1.19B |
| Dec 1992 | $1.25B(+60.4%) | - |
| Dec 1991 | $782.16M(+37.0%) | - |
| Dec 1990 | $570.97M | - |
FAQ
- What is AstraZeneca annual retained earnings?
- What is the all time high annual retained earnings for AstraZeneca?
- What is AstraZeneca annual retained earnings year-on-year change?
- What is the all time high quarterly retained earnings for AstraZeneca?
What is AstraZeneca annual retained earnings?
The current annual retained earnings of AZN is $3.16B
What is the all time high annual retained earnings for AstraZeneca?
AstraZeneca all-time high annual retained earnings is $18.27B
What is AstraZeneca annual retained earnings year-on-year change?
Over the past year, AZN annual retained earnings has changed by +$1.66B (+110.39%)
What is the all time high quarterly retained earnings for AstraZeneca?
AstraZeneca all-time high quarterly retained earnings is $18.61B